These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38631213)

  • 1. Advances in understanding and exploiting Siglec-glycan interactions.
    Jame-Chenarboo Z; Gray TE; Macauley MS
    Curr Opin Chem Biol; 2024 Jun; 80():102454. PubMed ID: 38631213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural advances of Siglecs: insight into synthetic glycan ligands for immunomodulation.
    Movsisyan LD; Macauley MS
    Org Biomol Chem; 2020 Aug; 18(30):5784-5797. PubMed ID: 32756649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow Cytometry-Based Detection of Siglec Ligands.
    Schmidt EN; Jung J; Macauley MS
    Methods Mol Biol; 2023; 2657():181-193. PubMed ID: 37149531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Status on Therapeutic Molecules Targeting Siglec Receptors.
    Lenza MP; Atxabal U; Oyenarte I; Jiménez-Barbero J; Ereño-Orbea J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33333862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglec Signaling in the Tumor Microenvironment.
    van Houtum EJH; Büll C; Cornelissen LAM; Adema GJ
    Front Immunol; 2021; 12():790317. PubMed ID: 34966391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the binding specificities of human Siglecs by cell-based glycan arrays.
    Büll C; Nason R; Sun L; Van Coillie J; Madriz Sørensen D; Moons SJ; Yang Z; Arbitman S; Fernandes SM; Furukawa S; McBride R; Nycholat CM; Adema GJ; Paulson JC; Schnaar RL; Boltje TJ; Clausen H; Narimatsu Y
    Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33893239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
    Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
    Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siglecs as modulators of macrophage phenotype and function.
    Kukan EN; Fabiano GL; Cobb BA
    Semin Immunol; 2024 May; 73():101887. PubMed ID: 39357273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siglec Ligands.
    Gonzalez-Gil A; Schnaar RL
    Cells; 2021 May; 10(5):. PubMed ID: 34065256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tools to study and target the Siglec-sialic acid axis in cancer.
    Läubli H; Kawanishi K; George Vazhappilly C; Matar R; Merheb M; Sarwar Siddiqui S
    FEBS J; 2021 Nov; 288(21):6206-6225. PubMed ID: 33251699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands.
    Rodrigues E; Jung J; Park H; Loo C; Soukhtehzari S; Kitova EN; Mozaneh F; Daskhan G; Schmidt EN; Aghanya V; Sarkar S; Streith L; St Laurent CD; Nguyen L; Julien JP; West LJ; Williams KC; Klassen JS; Macauley MS
    Nat Commun; 2020 Oct; 11(1):5091. PubMed ID: 33037195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate Sulfation As a Mechanism for Fine-Tuning Siglec Ligands.
    Jung J; Enterina JR; Bui DT; Mozaneh F; Lin PH; Nitin ; Kuo CW; Rodrigues E; Bhattacherjee A; Raeisimakiani P; Daskhan GC; St Laurent CD; Khoo KH; Mahal LK; Zandberg WF; Huang X; Klassen JS; Macauley MS
    ACS Chem Biol; 2021 Nov; 16(11):2673-2689. PubMed ID: 34661385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment.
    van de Wall S; Santegoets KCM; van Houtum EJH; Büll C; Adema GJ
    Trends Immunol; 2020 Apr; 41(4):274-285. PubMed ID: 32139317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Analysis of Siglec Ligands by Flow Cytometry.
    Chang LY; Sridharan D; Angata T
    Curr Protoc; 2023 Dec; 3(12):e949. PubMed ID: 38050649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of Recombinant Siglecs and Identification of Their Ligands.
    Chang LY; Low PY; Sridharan D; Gerlovin K; Angata T
    Methods Mol Biol; 2020; 2132():85-98. PubMed ID: 32306317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
    Meyer SJ; Linder AT; Brandl C; Nitschke L
    Front Immunol; 2018; 9():2820. PubMed ID: 30559744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
    Linnartz-Gerlach B; Mathews M; Neumann H
    Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human sialoglycan ligands for immune inhibitory Siglecs.
    Gonzalez-Gil A; Li TA; Kim J; Schnaar RL
    Mol Aspects Med; 2023 Apr; 90():101110. PubMed ID: 35965135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialoside analogue arrays for rapid identification of high affinity siglec ligands.
    Blixt O; Han S; Liao L; Zeng Y; Hoffmann J; Futakawa S; Paulson JC
    J Am Chem Soc; 2008 May; 130(21):6680-1. PubMed ID: 18452295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells.
    Tsubata T
    Int Immunol; 2023 Oct; 35(10):461-473. PubMed ID: 37504378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.